DiaSorin S.p.A. (DSRLF)
USD 106.85
(0.0%)
USD 106.85
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.54 Billion USD | -2.82% |
| 2022 | 3.64 Billion USD | -0.68% |
| 2021 | 3.67 Billion USD | 140.82% |
| 2020 | 1.52 Billion USD | 27.75% |
| 2019 | 1.19 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.84 Billion EUR | -17.76% |
| 2024 Q2 | 3.12 Billion EUR | 18.35% |
| 2023 Q4 | 3.21 Billion EUR | 3.75% |
| 2023 FY | 3.54 Billion USD | -2.82% |
| 2023 Q2 | 3.49 Billion USD | 5.79% |
| 2023 Q3 | 3.09 Billion EUR | -11.44% |
| 2023 Q1 | 3.3 Billion EUR | -9.41% |
| 2022 Q3 | 2.55 Billion EUR | -25.79% |
| 2022 FY | 3.64 Billion USD | -0.68% |
| 2022 Q1 | 3.55 Billion EUR | 10.05% |
| 2022 Q2 | 3.43 Billion EUR | -3.31% |
| 2022 Q4 | 3.64 Billion USD | 42.97% |
| 2021 Q2 | 1.85 Billion EUR | 36.74% |
| 2021 FY | 3.67 Billion USD | 140.82% |
| 2021 Q3 | 3.15 Billion EUR | 69.69% |
| 2021 Q4 | 3.23 Billion EUR | 2.41% |
| 2021 Q1 | 1.35 Billion EUR | 9.08% |
| 2020 Q1 | 1.06 Billion EUR | 0.06% |
| 2020 Q3 | 1.16 Billion EUR | 2.65% |
| 2020 Q4 | 1.24 Billion EUR | 7.1% |
| 2020 FY | 1.52 Billion USD | 27.75% |
| 2020 Q2 | 1.13 Billion EUR | 6.54% |
| 2019 FY | 1.19 Billion USD | 0.0% |
| 2019 Q4 | 1.06 Billion EUR | 10.81% |
| 2019 Q3 | 959.77 Million EUR | -14.67% |
| 2019 Q2 | 1.12 Billion EUR | 22.96% |
| 2019 Q1 | 914.75 Million EUR | -11.86% |
| 2018 Q4 | 1.03 Billion EUR | 7.72% |
| 2018 Q3 | 963.43 Million EUR | -9.42% |
| 2018 Q2 | 1.06 Billion EUR | 2.92% |
| 2018 Q1 | 1.03 Billion EUR | -8.91% |
| 2017 Q4 | 1.13 Billion EUR | 26.58% |
| 2017 Q2 | 963.03 Million EUR | 12.94% |
| 2017 Q1 | 852.66 Million EUR | -6.74% |
| 2017 Q3 | 896.34 Million EUR | -6.92% |
| 2016 Q2 | 866.51 Million EUR | 4.4% |
| 2016 Q1 | 830.01 Million EUR | 7.96% |
| 2016 Q3 | 914.42 Million EUR | 5.53% |
| 2016 Q4 | 914.23 Million EUR | -0.02% |
| 2015 Q1 | 723.48 Million EUR | -1.32% |
| 2015 Q4 | 768.83 Million EUR | 3.08% |
| 2015 Q3 | 745.87 Million EUR | 3.36% |
| 2015 Q2 | 721.63 Million EUR | -0.26% |
| 2014 Q1 | 765.77 Million EUR | 5.59% |
| 2014 Q2 | 736.37 Million EUR | -3.84% |
| 2014 Q3 | 726.39 Million EUR | -1.36% |
| 2014 Q4 | 733.14 Million EUR | 0.93% |
| 2013 Q2 | 642.02 Million EUR | -2.63% |
| 2013 Q3 | 688.53 Million EUR | 7.24% |
| 2013 Q1 | 659.36 Million EUR | 0.0% |
| 2013 Q4 | 725.21 Million EUR | 5.33% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -279221.803% |
| Arrayit Corporation | 1 Million USD | -354221.537% |
| Atlantic International Corp. | 4.43 Million USD | -79798.676% |
| Biocept, Inc. | 30.87 Million USD | -11381.209% |
| Bioqual, Inc. | 56.58 Million USD | -6163.874% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -1528190.051% |
| DermTech, Inc. | 121.93 Million USD | -2807.073% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 15.302% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -19838.477% |
| iMD Companies, Inc. | 190.13 Thousand USD | -1864131.413% |
| IDenta Corp. | 1.52 Million USD | -231682.621% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -27122.131% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -42854.812% |
| InVitro International | 1.53 Million USD | -230967.634% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -13107.369% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -153312775.476% |
| Medical Imaging Corp. | 4.19 Million USD | -84463.671% |
| NovelStem International Corp. | 2.25 Million USD | -157119.843% |
| Optigenex Inc. | 1.88 Million USD | -187614.476% |
| PharmChem, Inc. | 2.76 Million USD | -128069.158% |
| Proteome Sciences plc | 14.58 Million USD | -24201.287% |
| Response Genetics, Inc | 48.88 Million USD | -7151.03% |
| Rennova Health, Inc. | 20.57 Million USD | -17129.547% |
| RushNet, Inc. | 6.04 Million USD | -58511.547% |
| ScreenPro Security Inc. | 1.26 Million USD | -280913.865% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -750200.828% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -505799.317% |
| Todos Medical Ltd. | 15.26 Million USD | -23117.356% |